Inhibition of COX1 in human platelet rich plasma in assessed as inhibition of ADP-induced platelet aggregation at 10 uM incubated for 5 mins by turbidimetry based Born's method relative to control
Inhibition of COX2 in mouse RAW264.7 cells assessed as reduction in LPS-induced inflammation by measuring PGE2 level at 1 uM treated 1 hr after LPS stimulation and measured after 18 hrs by ELISA (Rvb = (2437 +/- 93.17 pg/mL)
Inhibition of COX2 in mouse RAW264.7 cells assessed as reduction in LPS-induced inflammation by measuring PGE2 level at 100 uM treated 1 hr after LPS stimulation and measured after 18 hrs by ELISA (Rvb = (2437 +/- 93.17 pg/mL)
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as pain threshold of ipsilateral paw at 30 mg/kg, po starting from day 14 after CFA injection and measured at 15 mins by paw pressure test (Rvb = 40.1 +/- 0.7 g)
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as pain threshold of ipsilateral paw at 30 mg/kg, po starting from day 14 after CFA injection and measured at 30 mins by paw pressure test (Rvb = 40.1 +/- 0.7 g)
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as pain threshold of ipsilateral paw at 30 mg/kg, po starting from day 14 after CFA injection and measured at 45 mins by paw pressure test (Rvb = 40.1 +/- 0.7 g)
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as increase in pain threshold of ipsilateral paw at 3 to 30 mg/kg, po starting from day 14 after CFA injection and measured at 0 to 60 mins by paw pressure test
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as effect on pain threshold of ipsilateral paw at 30 mg/kg, po starting from day 14 after CFA injection and measured at 60 mins by paw pressure test
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as increase in pain threshold of ipsilateral paw at 10 mg/kg, po starting from day 14 after CFA injection and measured at 15 mins by paw pressure test
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as increase in pain threshold of ipsilateral paw at 10 mg/kg, po starting from day 14 after CFA injection and measured at 30 mins by paw pressure test
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as increase in pain threshold of ipsilateral paw at 10 mg/kg, po starting from day 14 after CFA injection and measured at 45 mins by paw pressure test
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as pain threshold of ipsilateral paw at 3 mg/kg, po starting from day 14 after CFA injection and measured at 30 mins by paw pressure test (Rvb = 40.1 +/- 0.7 g)
Antihyperalgesic activity in Sprague-Dawley rat model of Complete freund's adjuvant-induced arthritis assessed as reduction in difference between weight burdened on contralateral and ipsilateral paw at 3 to 30 mg/kg, po starting from day 14 after CFA injection and measured at 0 to 60 mins incapacitance test